Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis

Am J Hematol. 2019 Jan;94(1):E11-E13. doi: 10.1002/ajh.25320. Epub 2018 Nov 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Drugs, Investigational / therapeutic use*
  • Female
  • Humans
  • Infections / etiology
  • Infections / mortality
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Renal Insufficiency / etiology
  • Renal Insufficiency / mortality
  • Retrospective Studies
  • Risk Factors
  • Salvage Therapy
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Drugs, Investigational